On August 31, 2023 Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics and Triclonics), reported that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will participate in the following investor conferences (Press release, Merus, AUG 31, 2023, View Source [SID1234634811]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 2023 18th Annual BioPharma Conference (fireside chat): Thursday, September 7 at 2:40-3:25 p.m. ET
Morgan Stanley 21st Annual Global Healthcare Conference: Wednesday, September 13 12:55-1:25 p.m. ET

The webcasts of the presentations will be contemporaneously available on the Investors page of the Company’s website. Archived presentations will also be available there for a limited time after the event.

On August 31, 2023 Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") reported that Dr. Helen Torley, president and chief executive officer, is scheduled to present and host investor meetings at the following investor conferences (Press release, Halozyme, AUG 31, 2023, View Source [SID1234634810]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details on the presentations are as follow:

Event:

2023 Wells Fargo Healthcare Conference

Format:

Fireside Chat and 1×1 Meetings

Presentation Date:

Thursday, September 7, 2023

Presentation Time:

8:00 a.m. ET / 5:00 a.m. PT

Location:

Boston, MA

Event:

H.C. Wainwright 25th Annual Global Investment Conference

Format:

Fireside Chat and 1×1 Meetings

Presentation Date:

Monday, September 11, 2023

Presentation Time:

9:30 a.m. ET / 6:30 a.m. PT

Location:

New York, NY

Event:

Morgan Stanley 21st Annual Global Healthcare Conference

Format:

Fireside Chat and 1×1 Meetings

Presentation Date:

Tuesday, September 12, 2023

Presentation Time:

10:50 a.m. ET / 7:50 a.m. PT

Location:

New York, NY

Event:

Baird 2023 Global Healthcare Conference

Format:

Fireside Chat and 1×1 Meetings

Presentation Date:

Wednesday, September 13, 2023

Presentation Time:

1:25 p.m. ET / 10:25 a.m. PT

Location:

New York, NY

A live audio webcast of the Wells Fargo, H.C. Wainwright and Morgan Stanley presentations will be available in the Investor Relations section of the Company’s website. Replays of the audio webcasts will be available for 90 days following the conference.

On August 31, 2023 UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, reported that it will present at the following investor conferences in September (Press release, UroGen Pharma, AUG 31, 2023, View Source [SID1234634808]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 25th Annual Global Investment Conference — September 11-13, 2023

Presentation: Tuesday, September 12th at 10:00 AM ET
Webcast Link: View Source

2023 Cantor Fitzgerald Global Healthcare Conference — September 26 – 28, 2023

Fireside Chat: Tuesday, September 26th at 8:35 AM ET
Webcast Link: View Source
Webcasts for both conferences will be available via the Investors section of UroGen’s website, www.urogen.com. A replay of each webcast will be available on the Company’s website for approximately 90 days.

On August 31, 2023 Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultrarare genetic diseases, reported that Emil D. Kakkis, M.D., Ph.D., the company’s chief executive officer and president, will participate in a panel discussion at Citi’s 18th Annual BioPharma Conference on Wednesday, September 6, 2023, at 8:50 a.m. EST and a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference on Tuesday, September 12, 2023, at 8:50 a.m. EST (Press release, Ultragenyx Pharmaceutical, AUG 31, 2023, View Source [SID1234634807]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The live and archived webcast of the panel and fireside chat will be accessible from the company’s website at View Source

On August 31, 2023 Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, reported that Michael A. Metzger, Chief Executive Officer of Syndax, will participate in a Targeted Oncology panel discussion at the Citi 18th Annual BioPharma Conference on Wednesday, September 6, 2023 at 1:00 p.m (Press release, Syndax, AUG 31, 2023, View Source [SID1234634806]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the panel discussion can be accessed from the Investor section of the Company’s website at www.syndax.com, where a replay of the events will also be available for a limited time.